Ayvakyt

avapritinib · Blueprint Medicines Netherlands B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ayvakyt, covering 2026-01-09 to 2026-01-09. Get the full timeline:

Most recent: EMA Authorised: Ayvakyt (avapritinib) — Blueprint Medicines (Netherlands) B.V.